The global Human Organoids market accrued earnings worth approximately 1.3 (USD Billion) in 2020 and is predicted to gain revenue of about 2.9(USD Billion) by 2028, is set to record a CAGR of nearly 17.3% over the period from 2021 to 2028.
The global Human Organoids market accrued earnings worth approximately 1.3 (USD Billion) in 2020 and is predicted to gain revenue of about 2.9(USD Billion) by 2028, is set to record a CAGR of nearly 17.3% over the period from 2021 to 2028. The report offers assessment and analysis of the Human Organoids market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).
Report Attribute | Details |
---|---|
Base Year | 2020 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
Dependence of biological research activities on animal prototypes have proven to be challenging tasks for addressing questions particular to understanding of human ailment. However, with onset of human organoids it is possible for re-creating physiology & architecture of human organs in comprehensive detail. In addition to this, human organoids offer new avenues for studying human ailment as well as supplement animal models. They have been utilized for studying contagious ailments, genetic diseases, and cancers through use of genetically engineering of stem cells of human beings. Apart from this, human organoids have the ability of reducing requirement for animal tests. Organoids are produced from human cell sources encompassing induced pluripotent stem cells, adult tissue-specific stem tissues, and embryonic stem cells.
With organoids having ability of studying human growth and model disease procedures with scrutiny & comprehensive analysis same as research on non-human models, the market for human organoids is anticipated to spur in the upcoming years. In addition to this, patient-based human organoids are likely to speed up healthcare research activities. Moreover, they are expected to create novel avenues for regenerative medicine & tissue engineering processes, thereby driving market trends. Apparently, human organoids have ability for producing information & tools for preclinical tests such as medicine testing & development. They can help in proficiently studying of complex ailment phenotypes and genetic difference among persons through utilization of patient-derived tissue cells. All these aforementioned aspects will drive growth of human organoids industry over forecast timespan.
Furthermore, breakthroughs in stem cell researches have brought a paradigm shift in field of medicine & biology, thereby paving a way for discovery in human biology & healthcare advancements. Furthermore, human organoids – an in vitro 3D structures- is a key revolution that recapitulate developing & tissue organizing as well as resembling body organs in humans. This, in turn, will create lucrative growth avenues for human organoids industry over assessment timeline. Human organoids possesses potential of overcoming limitations of biomedical studies targeted at getting mechanistic insights into human growth, producing patient-matching cell tissue sources for production of regenerative drugs, and generating human disease models. This will further expedite market size in the upcoming years. Major applications of human organoids (also referred as 3D organoids) include disease modelling, tissue engineering, organ development, transplantation, senescence, organogenesis, and differentiation pathways. In addition to this, human organoids find lucrative use in bio-banking due to breakthroughs in personalized medicine & cellular reprogramming sectors. They are also used as major tools for modelling cancer, neuropsychiatric ailments, and neurodegenerative disorders, and evolutionary studies. All these above-mentioned aspects will steer business space over the decade to come.
North America To Lead Overall Market Growth Over 2021-2028
The expansion of human organoids industry in North America during forecast period is due to large-scale use of human organoids by CROs, pharma firms, universities, and biotech firms in countries such as the U.S. and Canada. In addition to this, high acceptance of new techniques in medical sector along with large-scale annual spending on healthcare activities by Canadian and the U.S. governments will spearhead growth of human organoids market in sub-continent over the upcoming years. Favorable government guidelines pertaining to use of human organoids in pharma, healthcare, drug development, and medical research or biotech sectors will create lucrative growth avenues for human organoids market in North America over the assessment period.
Key participants profiled in the study and enlarging business scope include BioIVT, ZenBio, Thermo Fisher Scientific, Cyprio, Corning, CELLINK, Biopredic International, Hurel Corporation, Emulate, Kerafast, InSphero, MIMETAS, and Kirkstall.
By End-User
By Usability
By Product
By Application
By Region
List of Figures
1. Market research Type
2. Market research methodology
3. Global Human Organoids Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Human Organoids Marketattractiveness, By End-User
6. Global Human Organoids Marketattractiveness, By Usability
7. Global Human Organoids Marketattractiveness, By Product
8. Global Human Organoids Marketattractiveness, By Application
9. Global Human Organoids Marketshare by End-User ,2020 and 2028 (USD Billion)
10. Global Human Organoids Marketby Pharma-Biotech, 2018–2028(USD Billion)
11. Global Human Organoids Marketby Academia, 2018–2028(USD Billion)
12. Global Human Organoids Marketby CROs, 2018–2028(USD Billion)
13. Global Human Organoids Marketshare by Usability ,2020 and 2028 (USD Billion)
14. Global Human Organoids Marketby Customized, 2018–2028(USD Billion)
15. Global Human Organoids Marketby Ready-To-Use, 2018–2028(USD Billion)
16. Global Human Organoids Marketshare by Product ,2020 and 2028 (USD Billion)
17. Global Human Organoids Marketby Pancreas, 2018–2028(USD Billion)
18. Global Human Organoids Marketby Lung, 2018–2028(USD Billion)
19. Global Human Organoids Marketby , Kidney, 2018–2028(USD Billion)
20. Global Human Organoids Marketby Liver Models, 2018–2028(USD Billion)
21. Global Human Organoids Marketby GIT, 2018–2028(USD Billion)
22. Global Human Organoids Marketshare by Application ,2020 and 2028 (USD Billion)
23. Global Human Organoids Marketby Toxicity, 2018–2028(USD Billion)
24. Global Human Organoids Marketby Pathology, 2018–2028(USD Billion)
25. Global Human Organoids Marketby Personalized & Regenerative Drugs, 2018–2028(USD Billion)
26. Global Human Organoids Marketshare, by Region, 2020 and 2028
27. North America Human Organoids Market, 2018–2028(USD Billion)
28. Europe Human Organoids Market, 2018–2028(USD Billion)
29. Asia Pacific Human Organoids Market, 2018–2028(USD Billion)
30. Latin America Human Organoids Market, 2018–2028(USD Billion)
31. The Middle East and Africa Human Organoids Market, 2018–2028(USD Billion)
List of Tables
1. Global Human Organoids Market: snapshot
2. Drivers of the Human Organoids Market: impact analysis
3. North America Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
4. North America Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
5. North America Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
6. North America Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
7. The U.S. Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
8. The U.S. Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
9. The U.S. Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
10. The U.S. Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
11. Rest of North America Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
12. Rest of North America Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
13. Rest of North America Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
14. Rest of North America Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
15. Europe Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
16. Europe Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
17. Europe Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
18. Europe Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
19. UK Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
20. UK Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
21. UK Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
22. UK Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
23. France Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
24. France Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
25. France Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
26. France Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
27. Germany Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
28. Germany Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
29. Germany Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
30. Germany Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
31. Rest of Europe Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
32. Rest of Europe Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
33. Rest of Europe Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
34. Rest of Europe Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
35. Asia Pacific Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
36. Asia Pacific Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
37. Asia Pacific Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
38. Asia Pacific Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
39. China Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
40. China Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
41. China Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
42. China Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
43. Japan Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
44. Japan Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
45. Japan Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
46. Japan Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
47. India Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
48. India Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
49. India Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
50. India Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
51. Rest of Asia Pacific Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
52. Rest of Asia Pacific Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
53. Rest of Asia Pacific Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
54. Rest of Asia Pacific Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
55. Latin America Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
56. Latin America Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
57. Latin America Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
58. Latin America Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
59. Brazil Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
60. Brazil Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
61. Brazil Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
62. Brazil Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
63. Rest of Latin America Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
64. Rest of Latin America Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
65. Rest of Latin America Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
66. Rest of Latin America Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
67. The Middle East and Africa Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
68. The Middle East and Africa Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
69. The Middle East and Africa Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
70. The Middle East and Africa Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
71. Saudi Arabia Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
72. Saudi Arabia Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
73. Saudi Arabia Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
74. Saudi Arabia Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
75. South Africa Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
76. South Africa Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
77. South Africa Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
78. South Africa Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
79. Rest of the Middle East & Africa Human Organoids Market revenue, By End-User ,2018–2028(USD Billion)
80. Rest of the Middle East & Africa Human Organoids Market revenue, By Usability ,2018–2028(USD Billion)
81. Rest of the Middle East & Africa Human Organoids Market revenue, By Product ,2018–2028(USD Billion)
82. Rest of the Middle East & Africa Human Organoids Market revenue, By Application ,2018–2028(USD Billion)
With organoids having ability of studying human growth and model disease procedures with scrutiny & comprehensive analysis same as research on non-human models, the market for human organoids is set to spur in the upcoming years. In addition to this, patient-based human organoids are likely to speed up healthcare research activities. Moreover, they are expected to create novel avenues for regenerative medicine & tissue engineering processes, thereby driving market trends. Apparently, human organoids have ability for producing information & tools for preclinical tests such as medicine testing & development. They can help in proficiently studying of complex ailment phenotypes and genetic difference among persons through utilization of patient-derived tissue cells. All these aforementioned aspects will drive growth of human organoids industry over forecast timespan.
Furthermore, breakthroughs in stem cell researches have brought a paradigm shift in field of medicine & biology, thereby paving a way for discovery in human biology & healthcare advancements. Furthermore, human organoids – an in vitro 3D structures- is a key revolution that recapitulate developing & tissue organizing as well as resembling body organs in humans. This, in turn, will create lucrative growth avenues for human organoids industry over assessment timeline.
According to Zion market research report, the global Human Organoids market accrued earnings worth approximately 1.3 (USD Billion) in 2020 and is predicted to gain revenue of about 2.9(USD Billion) by 2028, is set to record a CAGR of nearly 17.3% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to large-scale use of human organoids by CROs, pharma firms, universities, and biotech firms in countries such as the U.S. and Canada. In addition to this, high acceptance of new techniques in medical sector along with large-scale annual spending on healthcare activities by Canadian and the U.S. governments will spearhead growth of human organoids market in sub-continent over the upcoming years. Favorable government guidelines pertaining to use of human organoids in pharma, healthcare, drug development, and medical research or biotech sectors will create lucrative growth avenues for human organoids market in North America over the assessment period.
The key market participants include BioIVT, ZenBio, Thermo Fisher Scientific, Cyprio, Corning, CELLINK, Biopredic International, Hurel Corporation, Emulate, Kerafast, InSphero, MIMETAS, and Kirkstall.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed